Picture of Allergy Therapeutics logo

AGY Allergy Therapeutics Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Annual cashflow statement for Allergy Therapeutics, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

2017
June 30th
2018
June 30th
2019
June 30th
C2020
June 30th
2021
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.97-6.94.298.073.66
Depreciation
Non-Cash Items-0.6260.8141.440.976-0.813
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.8380.26-2.22-0.4761.42
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities0.178-3.85.612.58.4
Capital Expenditures-1.73-2.18-3.1-2.55-2.56
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.217-0.319-0.2540.038-0.077
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1.94-2.5-3.35-2.51-2.64
Financing Cash Flow Items-0.404-0.321-0.301
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.188-0.2949.54-0.431-2.03
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.28-6.5911.99.523.31

Or unlock with your email

Or unlock with your email